Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Cardiovascular Drugs. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cardiovascular Drugs Indian Medical PG Question 1: Which drug should not be given in a patient with hyperrenninemia?
- A. Beta blocker
- B. Calcium channel blocker
- C. ACE inhibitor
- D. None of the options (Correct Answer)
Cardiovascular Drugs Explanation: None of the options
- This is the correct answer because drugs used to treat hypertension often aim to **reduce renin activity** or its effects, making them appropriate for hyperreninemia.
- Hyperreninemia indicates an overactive **renin-angiotensin-aldosterone system (RAAS)**, and all the listed drug classes can be used to manage conditions associated with it [2].
*Beta blocker*
- **Beta-blockers** reduce renin secretion from the **juxtaglomerular cells** by blocking beta-1 adrenergic receptors [2].
- Therefore, they are often used to *treat* conditions involving high renin levels, making them suitable rather than contraindicated.
*Calcium channel blocker*
- **Calcium channel blockers** reduce peripheral vascular resistance and can lower blood pressure, but they do not directly inhibit renin secretion [1].
- However, they are not contraindicated in hyperreninemia and may be used as part of a multidrug regimen to control blood pressure.
*ACE inhibitor*
- **ACE inhibitors** block the conversion of **angiotensin I to angiotensin II**, thus directly interrupting the RAAS pathway [1].
- This action helps to *lower* blood pressure and can be beneficial in hyperreninemia, making it a treatment rather than a contraindicated drug [1].
Cardiovascular Drugs Indian Medical PG Question 2: Drug of choice for beta antagonist toxicity is?
- A. Adrenaline
- B. Glucagon (Correct Answer)
- C. ACE inhibitors
- D. Dopamine
Cardiovascular Drugs Explanation: ***Glucagon***
- **Glucagon** is the drug of choice for **beta-blocker overdose** because it bypasses the beta-adrenergic receptors and directly activates **adenylate cyclase** to increase intracellular cAMP [1].
- This action leads to increased heart rate and myocardial contractility, counteracting the cardiac depression caused by beta-blockers [1].
*Adrenaline*
- **Adrenaline** (epinephrine) is a beta-agonist, but its effects are blunted in severe **beta-blocker overdose** due to **competitive antagonism** at beta receptors.
- While it can be used for its alpha-agonist effects to increase blood pressure, its efficacy in reversing profound bradycardia and myocardial depression may be limited.
*ACE inhibitors*
- **ACE inhibitors** are used in the management of hypertension and heart failure, primarily by reducing **angiotensin II** formation and inhibiting **bradykinin** degradation.
- They have no direct role in reversing the immediate cardiovascular effects of **beta-antagonist toxicity**.
*Dopamine*
- **Dopamine** is a **catecholamine** with dose-dependent effects, including positive inotropy and chronotropy at higher doses, but it relies on **adrenergic receptor activation**.
- Its effects can be attenuated in **beta-blocker overdose**, similar to adrenaline, making it less effective than glucagon as first-line therapy.
Cardiovascular Drugs Indian Medical PG Question 3: A 45-year-old female presents with dyspnea, orthopnea, and bilateral leg edema. Echo shows EF 35%. BNP 850 pg/mL. Which drug class has shown mortality benefit in this condition?
- A. Calcium channel blockers
- B. Alpha blockers
- C. Nitrates
- D. Beta blockers (Correct Answer)
Cardiovascular Drugs Explanation: ***Beta blockers***
- In **heart failure with reduced ejection fraction (HFrEF)**, beta blockers (e.g., carvedilol, metoprolol succinate, bisoprolol) significantly reduce **mortality** and hospitalizations [1].
- They work by blocking the adverse effects of **sympathetic nervous system activation** on the heart, improving cardiac remodeling and function over time.
*Calcium channel blockers*
- Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem) generally have **negative inotropic effects** and can worsen outcomes in HFrEF.
- While some dihydropyridine calcium channel blockers (e.g., amlodipine) are considered safe, they do **not confer a mortality benefit** in this condition.
*Alpha blockers*
- Alpha blockers like prazosin are primarily used for **hypertension** and **benign prostatic hyperplasia**.
- They have **not shown mortality benefit** in heart failure and may even cause symptomatic **hypotension**.
*Nitrates*
- Nitrates (e.g., isosorbide dinitrate, nitroglycerin) are effective **vasodilators** that reduce preload and afterload, alleviating symptoms like dyspnea [1].
- However, they do not consistently **reduce mortality** when used alone in HFrEF and are often combined with hydralazine for specific populations (e.g., African Americans).
Cardiovascular Drugs Indian Medical PG Question 4: Which of the following is not used in heart failure?
- A. Sacubitril
- B. Metoprolol
- C. Trimetazidine (Correct Answer)
- D. Nesiritide
Cardiovascular Drugs Explanation: ***Trimetazidine***
- While it has an anti-ischemic effect and can be used in **stable angina**, trimetazidine is *not* a primary or established drug for **heart failure** treatment.
- Its mechanism involves metabolic modulation rather than direct hemodynamic or neurohormonal benefits critical for heart failure.
*Sacubitril*
- Sacubitril is a **neprilysin inhibitor**, often combined with valsartan (an ARB) as **sacubitril/valsartan**, and is a cornerstone in managing **heart failure with reduced ejection fraction (HFrEF)**.
- It enhances beneficial natriuretic peptides, leading to vasodilation, natriuresis, and reduced cardiac remodeling.
*Metoprolol*
- **Beta-blockers** like metoprolol are essential in heart failure management, particularly in **HFrEF**, to reduce mortality and morbidity.
- They work by blocking the effects of norepinephrine and epinephrine, thereby reducing heart rate, myocardial contractility, and preventing adverse cardiac remodeling.
*Nesiritide*
- Nesiritide is a **recombinant human B-type natriuretic peptide (BNP)** that is used intravenously in the acute setting for **decompensated heart failure**.
- It promotes vasodilation, diuresis, and natriuresis, helping to reduce preload and afterload.
Cardiovascular Drugs Indian Medical PG Question 5: Identify the correct match, regarding the drug and its adverse effect.
- A. Aliskiren - hypokalemia
- B. Hydralazine - heart failure
- C. Atenolol - hemolytic anemia
- D. Verapamil - constipation (Correct Answer)
Cardiovascular Drugs Explanation: ***Verapamil - Constipation***
- **Verapamil**, a **non-dihydropyridine calcium channel blocker**, frequently causes constipation due to its effect on smooth muscle in the gastrointestinal tract, leading to **decreased intestinal motility**.
- This adverse effect is common and often dose-dependent, making it a significant consideration in patient management.
*Aliskiren - hypokalemia*
- **Aliskiren**, a **direct renin inhibitor**, can cause **hyperkalemia** by reducing angiotensin II levels, which normally stimulate aldosterone secretion.
- It does not typically cause hypokalemia; rather, potassium-sparing effects are often observed.
*Hydralazine - heart failure*
- **Hydralazine** is a **vasodilator** used to treat hypertension and **heart failure** with reduced ejection fraction by reducing afterload.
- It does not cause heart failure; instead, it is often prescribed to improve cardiac function in patients with heart failure.
*Atenolol - hemolytic anemia*
- **Atenolol** is a **beta-blocker** primarily used for hypertension, angina, and arrhythmias.
- **Hemolytic anemia** is a rare adverse effect associated with certain drugs, but it is not a known or common side effect of atenolol.
More Cardiovascular Drugs Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
